Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

448 results about "Circulating cancer cell" patented technology

Circulating tumor cells (CTCs) are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation.

Circulating tumor cell recognition model training method and system based on deep learning

The invention provides a circulating tumor cell recognition model training method and system based on deep learning, and the method comprises the steps: obtaining a multi-channel pathological sample image set of circulating tumor cells, carrying out the cross-modal feature extraction of a multi-channel pathological sample image, generating a fusion feature vector containing the morphological features and microenvironment features of the cells, and carrying out the recognition of the circulating tumor cells through the fusion feature vector. A deep convolutional network with a multi-stage training strategy is constructed, network parameters of the deep convolutional network in the training process are verified and adjusted by adopting a hierarchical cross validation mechanism, and finally a final recognition model is generated based on the verified and adjusted network parameters. The final recognition model is configured to receive the clinical pathology image stream and output localization coordinates and classification confidence of circulating tumor cells. According to the method, a circulating tumor cell recognition result can conform to a cell space distribution rule and has clinical pathological diagnosis interpretability, and the problems of high false positive rate and insufficient cell subtype discrimination caused by neglecting of microenvironment interaction in a traditional method are solved.
Owner:363 HOSPITAL

Rapid detection system for micro-fluidic chip

The invention relates to the technical field of cell detection, in particular to a micro-fluidic chip rapid detection system, which comprises a sample pretreatment and fluid control module used for carrying out primary treatment on input sample cells and ensuring accurate flow of a sample in a micro-fluidic chip; the sensing detection and signal processing module is used for carrying out real-time detection on the preprocessed sample cells and sending a detected data signal to the circulating tumor cell capturing module; the circulating tumor cell capturing module is used for capturing circulating tumor cells according to the data signal; the optical sensor and the microfluidic channel are integrated, so that optical signals and fluorescence signals of sample cells are detected in real time, and the characteristics of the circulating tumor cells can be extracted more accurately; a magnetic field control technology and a multi-channel confinement microstructure design are introduced, and the shear stress is dynamically adjusted in combination with fluid, so that directional capture of circulating tumor cells is realized.
Owner:HOHHOT JUNYUAN PRECISION TECH CO LTD

Biomarker for early diagnosis of non-small cell lung cancer and application thereof

The invention belongs to the technical field of biology, and relates to a biomarker for early diagnosis of non-small cell lung cancer and application of the biomarker. The biomarker comprises a combination of secretory phosphoprotein 1, epithelial cell adhesion molecules and matrix metallopeptidase 14, and / or a combination of coding nucleic acid of the secretory phosphoprotein 1, coding nucleic acid of the epithelial cell adhesion molecules and coding nucleic acid of the matrix metallopeptidase 14. The coding nucleic acid comprises mRNA or cDNA. In a test set, a non-small cell lung cancer circulating tumor cell scoring diagnosis model constructed by taking the biomarker as the characteristic has the diagnosis accuracy of 87.5% and the sensitivity and specificity of 92.5% and 82.5% respectively. Compared with existing clinical tumor indexes, cancer can be found more early, and early screening of the non-small cell lung cancer is facilitated.
Owner:SUZHOU INST OF NANO TECH & NANO BIONICS CHINESE ACEDEMY OF SCI

Fluorescence colorimetric sensor for detecting circulating tumor cells and preparation method of fluorescence colorimetric sensor

The invention discloses a fluorescent colorimetric sensor for detecting circulating tumor cells and a preparation method of the fluorescent colorimetric sensor. The preparation method comprises the following steps: S4, adding a prepared detection antibody modified with horse radish peroxidase and used for detecting the circulating tumor cells, and incubating; s5, adding a Tris buffer solution and a H2O2 solution, and incubating; s6, preparing an EuMOF nanoflower solution; and S7, adding the EuMOF nanoflower solution and 3, 3 ', 5, 5'-tetramethyl benzidine to react, detecting the fluorescence intensity in the presence of circulating tumor cells with different concentrations by using a luminoscope, detecting the ultraviolet absorbance value in the presence of circulating tumor cells with different concentrations by using a multifunctional microplate reader, and constructing a fluorescence intensity-concentration working curve and an ultraviolet absorbance value-concentration working curve. The method is used for qualitative and quantitative analysis and detection of the circulating tumor cells, realizes bimodal signal response to the circulating tumor cells, and has high sensitivity and simplicity and convenience in operation.
Owner:GANNAN MEDICAL UNIV

Circulating tumor cell screening and separating device and circulating tumor cell detection method

The invention provides a circulating tumor cell screening and separating device and a circulating tumor cell detection method, and belongs to the technical field of medical detection.The circulating tumor cell screening and separating device comprises a chamber module, the chamber module is provided with a mixing chamber, a screening chamber and a waste liquid chamber, and the mixing chamber, the screening chamber and the waste liquid chamber are sequentially communicated; the control module is mounted on the cavity module, and the control module is arranged to be capable of controlling whether the liquid is discharged from the mixing cavity to the screening cavity or not according to the motion state of the control module; the temperature control module is installed in the cavity module, and the temperature control module is arranged to be capable of controlling the temperature in the mixing cavity; the magnetic enrichment module is arranged to be capable of forming a magnetic field in the mixing cavity; the CTCs screening and separating device has the advantages that the CTCs screening and separating device based on the immunomagnetic bead separation technology is provided, the device is compact in structure, small in size and convenient to operate, the function of simulating the human body constant-temperature environment to assist in reaction cultivation is achieved, and the reliability and the detection precision during detection are ensured.
Owner:NINGBO INST OF MATERIALS TECH & ENG CHINESE ACAD OF SCI +1

Method for capturing and releasing circulating tumor cells based on phage magnetic material

A method for capturing and releasing circulating tumor cells based on a phage magnetic material belongs to the technical field of biological materials, and adopts an M13 phage as a support, pIII protein gene display histidine is connected with a magnetic sphere, and pVIII protein modifies an MUC1 aptamer through a click reaction for capturing and releasing the circulating tumor cells. The capture efficiency of the prepared M13 phage magnetic material on CTC reaches 95.63%, the release efficiency is 89.98%, and the cell activity reaches 97.14%. Compared with a traditional method for direct modification by using a monovalent aptamer, the capture efficiency of the system in whole blood is improved by 46.4%, and the release efficiency is improved by 35%. The M13 bacteriophage magnetic material can also be used for diagnosing actual breast cancer samples and distinguishing subtypes of different breast cancers, also has good capture performance on EpCAM negative cells, and greatly reduces the omission ratio and false negative results of CTCs.
Owner:NORTHEASTERN UNIV CHINA

Hydrodynamic topological optimization design method of circulating tumor cell sorting structure

The invention relates to the technical field of biomedical engineering and microfluidics, in particular to a fluid dynamics topological optimization design method of a circulating tumor cell sorting structure, which comprises the following steps of: establishing a three-dimensional flow field model containing a key separation area in a preset design domain, dispersing by adopting a tetrahedral mesh and setting boundary conditions; the method comprises the following steps: establishing a multi-objective optimization function based on a maximized transverse focusing distance, a minimum shear force peak value and a total pressure drop, dispersing a design domain into units and endowing the units with density variables, and realizing global automatic topological optimization by adopting penalty material interpolation and minimum flow velocity threshold constraint. An optimization result is subjected to structural reconstruction processing to generate a CAD model adaptive to micro-nano machining, closed-loop feedback is formed through secondary verification and experimental verification of computational fluid mechanics, it is ensured that the design meets the requirements for sorting efficiency and cell activity, limitation of a traditional flow channel form is broken through, and the design freedom degree, manufacturability and application value are improved.
Owner:PAIDILAN (SUZHOU) BIOTECHNOLOGY CO LTD

Separation and culture method of circulating tumor cells

The invention discloses a circulating tumor cell enrichment and culture method and a kit. According to the invention, the circulating tumor cell line can be rapidly and efficiently established, and the circulating tumor cells which are convenient to store and are amplified in a large number can be obtained.
Owner:PEKING UNION MEDICAL COLLEGE HOSPITAL +1

Micro-fluidic chip for sorting circulating tumor cells based on double-helix structure and sorting method of micro-fluidic chip

The invention discloses a micro-fluidic chip for sorting circulating tumor cells based on a double-helix structure and a sorting method thereof, the micro-fluidic chip has the double-helix structure comprising an inner outlet, and the micro-fluidic chip comprises a primary screening channel for primarily focusing and separating circulating tumor cells; the secondary screening channel is directly connected with the primary screening channel and is used for carrying out secondary focusing separation on the circulating tumor cells subjected to primary screening; wherein the primary screening channel is separated into two branches after rotating into the chip, one branch is connected with the middle outlet and used for discharging unfocused particles and redundant liquid, and the other branch is connected with the secondary screening channel so as to continue focusing and separation of the particles; the micro-fluidic chip is provided with an inlet for injecting a liquid sample and three outlets, namely a middle outlet, a particle collection outlet and a waste outlet, so that the injection of the liquid sample and the collection of separated particles are realized. According to the invention, high-throughput screening of the circulating tumor cells is realized, and the separation efficiency is improved.
Owner:DALIAN UNIV OF TECH

Deactivation of circulating tumor cells (CTCs) in the bloodstream by electrostatic stimulation of the peripheral blood

A method for deactivating circulating cancer cells (CTCs). The method includes reducing viability of CTCs and / or destroying CTCs by applying a positive electrostatic field to bloodstream of a cancer patient.
Owner:NANO HESGARSAZAN SALAMAT ARYA

Circulating tumor cell automatic detection device based on micro-fluidic nano-chip and AI analysis and application

The invention belongs to the technical field of biological intelligent detection, and particularly relates to a circulating tumor cell automatic detection device based on a micro-fluidic nano chip and AI analysis and application. The device comprises a micro-fluidic chip module, an optical acquisition module, an image recognition module, a feedback control module and a liquid path control module, and can realize efficient enrichment, image recognition and dynamic fluidic regulation of circulating tumor cells in peripheral blood. By constructing a change trend model of an image frame sequence, cell state changes are recognized in real time, flow velocity and channel control instructions are output, and collaborative optimization of recognition precision and the sample utilization rate is achieved. The device is suitable for tumor early screening, curative effect monitoring and recurrence early warning scenes.
Owner:HANGZHOU WATSON BIOTECH INC +1

Blood transfusion strategy optimization system based on clinical indexes and molecular markers

The invention relates to the technical field of medical information, and particularly discloses a blood transfusion strategy optimization system based on clinical indexes and molecular markers, which comprises the following steps: firstly, collecting clinical indexes of a patient and molecular marker data derived from circulating tumor cells; standardized integration is carried out to construct a multi-dimensional feature set reflecting correlation between clinical dynamics and molecular features; key association rules are identified through data mining, quantitative abnormal expression profiles and risk hierarchical labels are generated for each patient according to the key association rules, the blood transfusion urgency state is evaluated in combination with real-time data, physiological responses and risk changes under different blood transfusion schemes are deduced, and the optimal individual blood transfusion strategy parameters are solved. Performing deduction verification on the strategy by constructing a patient-specific virtual simulation scene, comparing the strategy with historical data to calculate an expected efficiency deviation degree, and outputting a final execution scheme subjected to optimization verification; according to the invention, the transformation from static threshold transfusion to individualized dynamic prediction and optimized transfusion is realized.
Owner:THE SECOND AFFILIATED HOSPITAL TO NANCHANG UNIV

Micro-fluidic chip based on CRISPR-Cas12a and immunofluorescence visualization dual-mode joint detection

PendingCN119034834Asolve problems encounteredUnlimited samplingLaboratory glasswaresBiological testingMicroscope slidePolystyrene
The invention discloses a micro-fluidic chip based on CRISPR-Cas12a (Clustered Regularly Interspaced Short Palindromic Repeats-Cas12a) and immunofluorescence visualization dual-mode joint detection. The chip is composed of three layers, the bottom layer is a microscope glass slide, the middle layer is a PDMS block with a microchannel and a glass slide, and the uppermost layer is a polystyrene transparent shell for protecting the chip; a microarray is arranged in a microchannel in the chip, microsites coated with Epcam antibodies are distributed on the surface layer, the antibodies and CTC are combined and adhered to the chip, and efficient capture of the circulating tumor epithelial cells is achieved. The chip is matched with a PD-L1 positive CTCs detection kit for use. According to the micro-fluidic chip for jointly detecting the PD-L1 positive circulating tumor cells of the peripheral blood of the NSCLC patient based on the CRISPR-Cas12a and the immunofluorescence visualization dual mode, provided by the invention, the PD-L1 expression of the NSCLC patient and the monitoring and prognosis of the curative effect of immunotherapy can be conveniently and accurately predicted in a clinical non-invasive manner.
Owner:SHANGHAI CHEST HOSPITAL

A fully automatic circulating tumor cell enrichment device

The present invention relates to the technical field of fully automatic detection of circulating tumor cells; specifically, it is a fully automatic circulating tumor cell enrichment device, comprising: a chip storage unit, a first reagent storage unit, a second reagent storage unit, a sensing device, a shaking device and a transfer device; the first reagent storage unit comprises a plurality of cleaning liquid storage boxes and at least one waste liquid storage box; the second reagent storage unit comprises a plurality of test reagent storage racks arranged in sequence; the shaking device is used to fully shake the liquid injected into the chip storage unit and accelerate the reaction; the chip storage unit comprises a structure for storing a positive separation circulating tumor cell chip; the device realizes the fully automatic capture and staining function of circulating tumor cells in blood samples, has the advantages of easy use and standardized process, can provide standardized sample processing means for various tumors, such as prostate tumors and colon cancer tumors, and has important significance for basic research and clinical application of tumors.
Owner:TECHNICAL INST OF PHYSICS & CHEMISTRY - CHINESE ACAD OF SCI

Precise liquid treatment system and method based on multi-channel liquid distribution valve and gas replacement

The invention discloses a precise liquid treatment system and method based on a multi-channel liquid separation valve and gas replacement, and belongs to the technical field of biomedical detection equipment. The system comprises a multi-channel liquid distribution valve and an intelligent control system, the liquid distribution valve is provided with a plurality of channels which are respectively connected with four groups of coloring agent bottles, sheath liquid bottles, waste liquid bottles and gas bottles; a liquid level detection sensor is arranged between the liquid distribution valve and the peristaltic pump, and an outlet of the peristaltic pump is communicated with the dyeing pool. The method comprises the steps of cancer cell acquisition, fixed permeation treatment, system pre-filling, multiple fluorescent staining and fluorescent imaging. High-precision distribution of micro-liquid is realized through cooperative control of liquid separation valve channel switching and inert gas replacement, and high-precision and high-repeatability distribution of micro-upgrading liquid can be realized; a gas isolation mechanism significantly reduces the risk of cross contamination, multi-channel parallel processing improves the detection efficiency, and the device is suitable for circulating tumor cell multi-staining, flow analysis and other biomedical scenes needing high-precision liquid treatment.
Owner:INST OF PHYSICS HENAN ACAD OF SCI +1

Sorting microfluidic system, chip and preparation method thereof

The invention discloses a sorting microfluidic system which sequentially comprises a pretreatment unit, a sample introduction unit, a sorting unit and an outlet unit. The pretreatment unit comprises a centrifugal rotary filter membrane to filter out large-size CTC clusters; the sorting unit comprises a first micro-column array, the first micro-column array at least comprises a first-stage array and a second-stage array connected with the first-stage array in sequence, and the first micro-column array is used for separating CTCs with different sizes; the outlet unit includes a plurality of outlets for particles of different sizes. The sample introduction unit comprises a buffer solution inlet and a preliminary screening sample inlet, the number of gaps of the first micro-column array is configured to be different according to a first preset proportion, the centrifugal rotation moving membrane adopts a silicon nitride filtering membrane, and the microfluidic module is used for extracting circulating tumor cells CTCs.
Owner:SHANGHAI JIAOTONG UNIV +1

Multifunctional bionic nano preparation, preparation method and application

The invention belongs to the technical field of pharmaceutical preparations. The invention discloses a multifunctional bionic nano preparation, a preparation method and application. According to the multifunctional bionic nano preparation, the ginsenoside Rg3 has the dual functions of a medicine and a membrane stabilizer, the platelet membrane has the natural targeting capability on circulating tumor cells and metastases, and meanwhile, the cationic liposome is used for adsorbing negatively-charged NETs nucleic acid protein compounds, so that potential reversal and active targeting are achieved, and the multifunctional bionic nano preparation has a good application prospect. And by co-carrying paclitaxel (PTX) and a photothermal agent (PCP) and integrating photothermal-chemotherapy-immunogenic death (ICD) induction functions, the tumor-related fibroblast activation can be effectively inhibited, circulating tumor cells can be efficiently captured, a tumor immune microenvironment can be remodeled, the tumor cells can be effectively killed, and tumor distal metastasis can be inhibited.
Owner:WEIFANG UNIV OF SCI & TECH

Three-dimensional network chip and preparation method and application thereof

The invention discloses a three-dimensional network chip and a preparation method and application thereof, the three-dimensional network chip comprises a polydimethylsiloxane film, the polydimethylsiloxane film has a three-dimensional network skeleton structure, and the surface of the three-dimensional network skeleton structure is loaded with gel composed of titanium carbide-Mxene and graphene oxide. According to the three-dimensional network chip, the three-dimensional network PDMS thin film serves as a chip substrate, the functionalized titanium carbide-Mxene / graphene oxide gel is loaded on the surface of the substrate, the functionalized three-dimensional network chip is constructed, and the three-dimensional network thin chip can be used for capturing circulating tumor cells. By utilizing the synergistic effect of the three-dimensional network structure of the chip and the Mxene / graphite oxide functionalized surface, the adhesion promoting effect on cancer cells is improved, the yield of circulating tumor cells is increased, and the capture efficiency can reach 90% or above within 1 h.
Owner:INST OF BIOLOGICAL & MEDICAL ENG GUANGDONG ACAD OF SCI

Circulating tumor cell detection and analysis device

The invention discloses a circulating tumor cell detection and analysis device, and belongs to the field of cell detection. A circulating tumor cell detection and analysis device comprises a box body, a sample tube, a mixing device and a glass slide area, an operation panel and a PLC are arranged on the front face of the box body, the sample tube, the mixing device and the glass slide area are arranged in the box body, a circulating tumor cell detection system A is further arranged in the box body, and a dyeing quality monitoring system B is arranged on the mixing device. The problem that the detection result is not accurate and stable enough due to limitation in the prior art is solved, various characteristics of the circulating tumor cells can be accurately recognized by collecting the images and performing a series of operations in cooperation with the deep learning target detection network, a reliable basis is provided for diagnosis, and the detection efficiency is improved. By monitoring the fluorescence signal, the temperature, the pH value and the like in real time, the dyeing quality can be strictly controlled, the reliability of the detection result is ensured, and misdiagnosis caused by the dyeing problem is avoided.
Owner:SHENZHEN HENGRUI LIFE TECH CO LTD

Application of circulating tumor cells and circulating tumor DNA (Deoxyribose Nucleic Acid) of peritoneal lavage fluid to prediction of allogenic peritoneal metastasis after radical gastric cancer operation

ActiveCN118979107ATimely and effective formulationformulate effectiveMicrobiological testing/measurementDrug and medicationsOncologyAdvanced gastric cancer
The invention relates to the technical field of biology, in particular to detection of circulating tumor cells and circulating tumor DNA (deoxyribonucleic acid) based on abdominal cavity lavage fluid and application of the detection in predicting the risk of allogenic peritoneal metastasis after a radical gastric cancer operation. How to recognize micro-metastasis in the abdominal cavity and delay the occurrence and development of the micro-metastasis in a patient with gastric cancer in the progression stage becomes a problem urgently needing to be solved in the field of gastric surgery at present. The invention provides an application of detecting circulating tumor cells and circulating tumor DNA (ctDNA) in abdominal cavity lavage fluid to predict the risk of allogenic peritoneal metastasis after a radical gastric cancer operation. The latent peritoneal metastasis can be screened, judged and follow-up visited in multiple stages, more comprehensive and sensitive information is provided, and clinical decision making and treatment scheme making can be guided.
Owner:RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Model order reduction method for rapid optimization of circulating tumor cell (CTC) sorting structure

The invention relates to the technical field of computational fluid mechanics and biological microfluidic design, in particular to a model order reduction method for rapid optimization of a circulating tumor cell (CTC) sorting structure, which comprises the following steps of: constructing a three-dimensional full-order computational fluid mechanics model by collecting channel geometric structure parameters and fluid working condition parameters, and generating a training data set; organizing a flow field snapshot into a matrix form, extracting a dominant mode, constructing a low-dimensional modal space by taking the dominant mode as a base vector, establishing a low-dimensional ordinary differential model through Galerkin projection, and training a parameter-modal coefficient mapping relation by adopting a deep neural network to form a complete reduced-order model; and finally, constructing a multi-objective optimization problem based on the reduced-order model, carrying out optimization iteration by adopting an evolutionary algorithm, and returning an optimization result to the full-order model for verification, so that rapid optimization design of the CTC sorting structure is realized, and an effective solution is provided for intelligent design of a biomedical microfluidic device.
Owner:PAIDILAN (SUZHOU) BIOTECHNOLOGY CO LTD

Two-stage sorting micro-fluidic chip for separating and detecting circulating tumor cells as well as preparation method and application of two-stage sorting micro-fluidic chip

The invention discloses a two-stage sorting micro-fluidic chip for separating and detecting circulating tumor cells as well as a preparation method and application of the two-stage sorting micro-fluidic chip, and belongs to the technical field of micro-fluidic equipment and circulating tumor cell detection. The DLD chip designed and prepared by the invention has the advantage of high sorting precision, CTC can be separated from most blood cells, and the purity of CTC is remarkably improved; compared with a traditional single sorting chip, the two-stage cell sorting micro-fluidic chip provided by the invention can break through the limitation of a single sorting technology, integrates the advantages of a spiral chip and a DLD chip, and simultaneously realizes high-throughput sample treatment, high CTC recovery rate and high-purity CTC separation; the two-stage separation chip provided by the invention is a label-free separation strategy, has small damage to CTC, does not depend on CTC surface antigens, and can obtain representative CTC of different subtypes; three specific cancer aptamers and electrochemical signal molecules are selected for HCR assembly, and the dual functions of specific CTC recognition and CTC sensitive detection by generating electric signals are achieved.
Owner:THE AFFILIATED HOSPITAL OF XUZHOU MEDICAL UNIV

Circulating tumor cell detection kit as well as preparation method and use method thereof

The invention discloses a circulating tumor cell detection kit as well as a preparation method and a use method thereof, a capture probe takes ferroferric oxide nano as a core and hyaluronic acid as a modification material to coat the periphery of the ferroferric oxide nano so as to realize capture and magnetic separation of circulating tumor cells; the detection probe takes CdS (at) Au nanoparticles as a core, CuS (at) Au is generated through replacement of cadmium ions by copper ions, and folic acid is taken as a modification material to realize targeting of CdS (at) Au to circulating tumor cells. According to the present invention, the instant detection of the circulating tumor cells is achieved, the detection cost of the circulating tumor cells is reduced, the technical requirements of operators are reduced, and the problem of how to use the multi-mode detection method for the detection accuracy of the circulating tumor cells can be effectively solved.
Owner:NANHUA UNIV

Method for double-ring detection of lung cancer L858R mutation based on CRISPR / Cas9 and DNA

The invention relates to the technical field of biological detection, and discloses a method for double-ring detection of lung cancer L858R mutation based on CRISPR / Cas9 and DNA, and the method comprises the following steps: enriching circulating tumor cells CTC from a blood sample; extracting genomic DNA (deoxyribonucleic acid) of the enriched CTC; carrying out amplification on the DNA fragment containing the L858R mutation by adopting recombinase polymerase amplification RPA (recombinase polymerase amplification); the amplified DNA fragment is hybridized with a recognition ring in a DNA double-ring structure, a DNA double ring is composed of the recognition ring and a report ring, and a part of region of the recognition ring is hybridized with a corresponding fragment of the report ring to form a staggered double-chain region; when L858R mutation exists, the mutated DNA and a recognition ring are hybridized to activate a CRISPR / Cas9 system, and under the guidance of sgRNA, Cas9 cuts hybrid double strands and releases a report ring; carrying out rolling circle amplification RCA under the action of DNA polymerase by taking the released report ring as a template; a fluorescent probe is used for detecting an RCA amplification product, and whether L858R mutation exists or not is judged according to a fluorescence signal. The CRISPR / Cas9 system is combined with a DNA double-ring structure, so that the ultra-sensitive and specific detection on the lung cancer L858R mutation is realized.
Owner:重庆医科大学国际体外诊断研究院

Microfluidic chip PSMA prostate cancer circulating tumor cell immunoenrichment detection kit and preparation method thereof

ActiveCN120446482ABiological testingVimentin antibodyWhite blood cell
The invention belongs to the technical field of biochemical detection, and particularly relates to a micro-fluidic chip PSMA prostate cancer circulating tumor cell immunoenrichment detection kit and a preparation method thereof. According to the kit, an EpCAM antibody, a Vimentin antibody and a double-site PSMA capture combination are fixed in a chip channel through a streptavidin-biotin system, double enrichment of epithelial and mesenchymal CTCs is achieved, PSMA targets are recognized through combination of an aptamer and the antibody, and the detection specificity and sensitivity are improved. Competitive oligopeptides are further introduced to block non-specific binding sites on the surfaces of leukocytes and reduce false positive. By combining a multiple fluorescent chromosome system and a double-antibody nucleic acid probe signal amplification strategy, accurate recognition and quantification of CTC and PSMA positive cells are realized. The scheme is suitable for early screening, curative effect evaluation and relapse monitoring of prostate cancer, and has a good clinical application prospect.
Owner:HANGZHOU WATSON BIOTECH INC

Circulating tumor cell enriching, separating and dyeing integrated system and application thereof

The invention relates to a circulating tumor cell enrichment, separation and dyeing integrated system and application thereof.The circulating tumor cell enrichment, separation and dyeing integrated system is composed of a bottom plate module, a platform module, a multi-pipette module, a power module and a shell module; the platform module comprises a sample tube rotating and uniformly mixing module, a magnetic adsorption module, a reagent module, a waste liquid pool module and a gun head module, and the sample tube rotating and uniformly mixing module, the magnetic adsorption module and the reagent module are fixedly mounted on a bottom plate I in sequence. The CTC separation and dyeing integrated system is developed on the basis of the immunomagnetic bead technology, enrichment separation and immunofluorescent dyeing of CTC can be automatically completed by running a program, manual operation errors are effectively avoided through a programmed process, and the CTC separation and dyeing integrated system is particularly suitable for clinical CTC detection. The system is also suitable for other enrichment and separation applications based on an immunomagnetic bead technology, including but not limited to enrichment and separation of biological macromolecules such as cells, exosomes, proteins and the like.
Owner:BEIJING NANOPEP BIOTECH CORP LTD

Method for separating and analyzing circulating tumor cells

The present disclosure provides a method of isolating and analyzing circulating tumor cells (CTCs) in a biological sample by using flow cytometry. By using this method, the responsiveness of a subject suffering from lung cancer or gastric cancer to a treatment process can be predicted in a rapid and simple manner.
Owner:FULLHOPE BIOMEDICAL

System and method to detect, enumerate and characterize circulating tumor cells in patient's whole blood

The present disclosure pertains to a circulating tumor cell (CTC) microfluidic platform that is used for the detection of CTCs, enumeration of CTCs in a sample, characterization of biophysical properties, CTC cell size, CTC cell membrane deformability, stresses on CTC cell membranes, adhesion stress on CTC cells, normal stress of CTC cells, or combinations thereof.
Owner:TEXAS A&M UNIVERSITY

A circulating tumor cell detection system and electrochemical sensor preparation method

The present invention relates to a circulating tumor cell detection system and an electrochemical sensor preparation method, which relate to the field of computer vision. The system includes an acquisition module for acquiring cell images using an electrochemical sensor; a segmentation and extraction module for performing segmentation and extraction based on the cell images using a cell image segmentation model to obtain segmentation results; the cell image segmentation model is obtained by training a U-Net network using a transfer learning algorithm; and a Grad-CAM algorithm processing module for obtaining a tumor cell heat map based on the segmentation results using the Grad-CAM algorithm. The present invention can achieve accurate identification of CTCs.
Owner:SHANGHAI UNIV

Method and device for unmasking biological cells via plasmin activation

PCT designated stage expiredWO2025002764A1Biological material analysisPLG - PlasminogenBlood specimen
The invention relates to a method (500) and a device (100) for unmasking biological cells, in particular circulating tumor cells, by means of plasmin, wherein a reactant (10) is added to a sample containing plasminogen and biological cells, in particular a blood sample, in order to convert plasminogen to plasmin.
Owner:ROBERT BOSCH GMBH